Influence of hepatitis C virus eradication with direct-acting antivirals on the gut microbiota in patients with cirrhosis.
Francesca Romana PonzianiLorenza PutignaniFrancesco Paroni SterbiniValentina PetitoAnna PiccaFederica Del ChiericoSofia ReddelRiccardo CalvaniEmanuele MarzettiMaurizio SanguinettiAntonio GasbarriniMaurizio PompiliPublished in: Alimentary pharmacology & therapeutics (2018)
Cure of HCV infection with DAAs in patients with cirrhosis is associated with a modification of the gut microbiota, which correlates with fibrosis and inflammation but does not improve intestinal barrier function.